China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on Dedifferentiation Mechanism of Anaplastic Thyroid Carcinoma Based on Single Cell Sequencing Technology'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135899
Registration Time: 2026/11/03
Type: Observational study
Primary Sponsor: Wangjing Hospital of China Academy of Chinese Medical Sciences
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=218157
Published by HT Digital Content Services with permission from Health Daily Digest....